P53-miR-191- SOX4 regulatory loop affects apoptosis in breast cancer

High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor–Positive Metastatic Breast Cancer

(2016) Carla L. Alves et al.   CLINICAL CANCER RESEARCH

miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer

(2015) Yunhui Hu et al.   BREAST CANCER RESEARCH AND TREATMENT

Targeting CDK6 in cancer: State of the art and new insights

(2015) Solomon Tadesse et al.   CELL CYCLE

Methylation of PLCD1 and adenovirus-mediated PLCD1 overexpression elicits a gene therapy effect on human breast cancer

(2015) Haixi Mu et al.   EXPERIMENTAL CELL RESEARCH

Down-regulated SOX4 Expression Suppresses Cell Proliferation, Metastasis and Induces Apoptosis in Xuanwei Female Lung Cancer Patients

(2015) Yongchun Zhou et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients

(2015) Guo-Dong Song et al.   TUMOR BIOLOGY

HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGFβ-signaling in hypoxic microenvironment.

(2015) Neha Nagpal et al.   Scientific Reports

Predicting effective microRNA target sites in mammalian mRNAs

(2015) Vikram Agarwal et al.   eLife

miR-17/20 sensitization of breast cancer cells to chemotherapy-induced apoptosis requires Akt1

(2015) Zuoren Yu et al.   Oncotarget

Hypomethylation of the hsa-miR-191 Locus Causes High Expression of hsa-miR-191 and Promotes the Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma

(2015) Yinghua He et al.   NEOPLASIA

MicroRNA-191 promotes pancreatic cancer progression by targeting USP10

(2014) Hua Liu et al.   TUMOR BIOLOGY

MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer

(2013) Neha Nagpal et al.   CARCINOGENESIS

The Function Role of miR-181a in Chemosensitivity to Adriamycin by Targeting Bcl-2 in Low-Invasive Breast Cancer Cells

(2013) Ying Zhu et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

The p53-Estrogen Receptor Loop in Cancer

(2013) C. Berger et al.   CURRENT MOLECULAR MEDICINE

Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses

(2013) Joanna Obacz et al.   Molecular Cancer

Association of a Genetic Variation in a miR-191 Binding Site in MDM4 with Risk of Esophageal Squamous Cell Carcinoma

(2013) Liqing Zhou et al.   PLoS One

Association between TCF7L2 Gene Polymorphism and Cancer Risk: A Meta-Analysis

(2013) Jingxiang Chen et al.   PLoS One

Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status

(2013) Gianpiero Di Leva et al.   PLoS Genetics

MicroRNA-34a Modulates Chemosensitivity of Breast Cancer Cells to Adriamycin by Targeting Notch1

(2012) Xiu-juan Li et al.   ARCHIVES OF MEDICAL RESEARCH

Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells

(2012) Elisa Latorre et al.   Molecular Cancer

MicroRNA-191 targets N-deacetylase/N-sulfotransferase 1 and promotes cell growth in human gastric carcinoma cell line MGC803

(2011) X. Shi et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

MicroRNA-21 Modulates Chemosensitivity of Breast Cancer Cells to Doxorubicin by Targeting PTEN

(2011) Zhao-Xia Wang et al.   ARCHIVES OF MEDICAL RESEARCH

Brain-Derived Neurotrophic Factor and Neurotrophin-4/5 Are Expressed in Breast Cancer and Can Be Targeted to Inhibit Tumor Cell Survival

(2011) E. Vanhecke et al.   CLINICAL CANCER RESEARCH

Non-coding RNAs in cancer initiation and progression and as novel biomarkers

(2011) S. Patrick Nana-Sinkam et al.   Molecular Oncology

Tumor suppressor p53 meets microRNAs

(2011) Z. Feng et al.   Journal of Molecular Cell Biology

An Illegitimate microRNA Target Site within the 3' UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity

(2010) J. Wynendaele et al.   CANCER RESEARCH

hsa-miR-191 Is a Candidate Oncogene Target for Hepatocellular Carcinoma Therapy

(2010) E. Elyakim et al.   CANCER RESEARCH

SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro

(2010) Wonhee Hur et al.   CARCINOGENESIS

Doxorubicin pathways

(2010) Caroline F. Thorn et al.   Pharmacogenetics and Genomics

Overexpression of MicroRNA miR-30a or miR-191 in A549 Lung Cancer or BEAS-2B Normal Lung Cell Lines Does Not Alter Phenotype

(2010) Santosh Kumar Patnaik et al.   PLoS One

Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells

(2009) Qing-Quan Li et al.   CANCER SCIENCE

CCAAT/enhancer-binding protein β: its role in breast cancer and associations with receptor tyrosine kinases

(2009) Cynthia A. Zahnow   EXPERT REVIEWS IN MOLECULAR MEDICINE

Induction of SOX4 by DNA damage is critical for p53 stabilization and function

(2009) X. Pan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Resistance to chemotherapy: new treatments and novel insights into an old problem

(2008) S Raguz et al.   BRITISH JOURNAL OF CANCER